Quest Partners LLC Editas Medicine, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 17,458 shares of EDIT stock, worth $97,939. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,458
Previous 47,681
63.39%
Holding current value
$97,939
Previous $483 Million
73.18%
% of portfolio
0.02%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
249Shares Held
69.6MCall Options Held
564KPut Options Held
428K-
State Street Corp Boston, MA8.76MShares$49.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.56MShares$48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.83MShares$43.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.53MShares$31 Million1.35% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.61MShares$14.6 Million0.01% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $386M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...